Phase II Study of Nivolumab Plus Ipilimumab with Platinum-Based Chemotherapy for Treatment-Naïve Advanced Non-Small Cell Lung Cancer with Untreated Brain Metastases: NIke Trial (LOGiK2004)

Phase II Study of Nivolumab Plus Ipilimumab with Platinum-Based Chemotherapy for Treatment-Naïve Advanced Non-Small Cell Lung Cancer with Untreated Brain Metastases: NIke Trial (LOGiK2004)

Yuko Tsuchiya-Kawano,1 Yoshimasa Shiraishi,2 Fumiaki Kiyomi,3 Isamu Okamoto2 1Department of Respiratory Medicine, Kitakyushu Municipal Medical Center, Kitakyushu, Japan; 2Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan; 3Statistics...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Tsuchiya-Kawano Y, Shiraishi Y, Kiyomi F, Okamoto I
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2021
Materias:
clinical trial
nsclc
nivolumab plus ipilimumab
brain metastases
intracranial response rate
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Acceso en línea:https://doaj.org/article/7b71322540c543f7a6dd2e4c6e803a2a
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Internet

https://doaj.org/article/7b71322540c543f7a6dd2e4c6e803a2a

Ejemplares similares